Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Grifols's inventories, raw materials & components for the quarter that ended in Jun. 2026 was MXN0 Mil.
Grifols's quarterly raw materials
declined
from Dec. 2025 (MXN19,735 Mil) to Mar. 2026 (MXN0 Mil) but then
stayed the same
from Mar. 2026 (MXN0 Mil) to Jun. 2026 (MXN0 Mil).
Grifols's annual raw materials
increased
from Dec. 2023 (MXN20,219 Mil) to Dec. 2024 (MXN21,380 Mil) but then
declined
from Dec. 2024 (MXN21,380 Mil) to Dec. 2025 (MXN19,735 Mil).
Grifols Inventories, Raw Materials & Components Historical Data
* Premium members only.
The historical data trend for Grifols's Inventories, Raw Materials & Components can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Grifols Inventories, Raw Materials & Components Chart
What does a Inventories, Raw Materials & Components of MXN0 Mil mean?
Grifols (MEX:GRFP N) has a Inventories, Raw Materials & Components of MXN0 Mil as of Jun. 2026. Raw materials are the components a company uses for its main products. View historical data on Grifols and its competitors.
Is Grifols' Inventories, Raw Materials & Components too high?
Grifols' current Inventories, Raw Materials & Components is MXN0 Mil. Overall, Grifols has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does Grifols' Inventories, Raw Materials & Components compare to LLY and JNJ?
Grifols' Inventories, Raw Materials & Components of MXN0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Drug Manufacturers company?
A good Inventories, Raw Materials & Components depends on the Drug Manufacturers industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Grifols and its competitors. Grifols's current Inventories, Raw Materials & Components is MXN0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grifols stock overvalued right now?
Grifols (MEX:GRFP N) has a current Inventories, Raw Materials & Components of MXN0 Mil. The stock's GF Value™ is MXN132.54, compared to a current price of MXN126.63 — trading 4.5% below its estimated fair value. The current Inventories, Raw Materials & Components is MXN0 Mil. Grifols' overall GF Score™ is 75/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Grifols (MEX:GRFP N), the current Inventories, Raw Materials & Components is MXN0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Grifols (MEX:GRFP N) Overvalued in 2026?
Based on GuruFocus' analysis, Grifols stock appears to be undervalued.
The current stock price of MXN126.63 is trading 4.5% below its estimated GF Value™ of MXN132.54.
Key valuation signals for MEX:GRFP N:
Inventories, Raw Materials & Components: MXN0 Mil
GF Value™: MXN132.54 vs. price of MXN126.63 (4.5% below fair value)
No single metric tells the full story. See the MEX:GRFP N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.
75GF Score
Get the complete analysis for MEX:GRFP N
Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:GRFP N has been successfully added to your 
